European Journal of Cancer
Volume 41, Issue 4 , Pages 508-515 , March 2005

Does surgery unfavourably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastases?

  • Michael Baum

      Affiliations

    • Emeritus Surgery U.C.L., Consulting Rooms, Portland Hospital, 212–214 Great Portland Street, London WIW 5QN, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 2073908447; fax: +44 73908448
    • ,
  • Romano Demicheli

      Affiliations

    • Department of Medical Oncology, Milan National Cancer Institute, Via Venezian 1, 20133 Milan, Italy
    • ,
  • William Hrushesky

      Affiliations

    • School of Medicine and Arnold School of Public Health, The University of South Carolina, Columbia, SC 29208, USA
    • ,
  • Michael Retsky

      Affiliations

    • Children’s Hospital and Harvard Medical School, Department of Vascular Biology, 300 Longwood Avenue, Boston, MA 02115, USA

Received 9 September 2004 ,Accepted 21 September 2004.

References 

  1. Irving Ariel. A historical review of breast cancer treatment. In: Johnson, Wise, eds. Breast Cancer: Controversies in Management, 1994
  2. Daland EM. Untreated carcinoma of the breast. Surg Gynaecol Obstet. 1927;44:264–271
  3. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–573
  4. Gross SW. A Practical Treatise of Tumours of the Mammary Gland. Nework: D. Appelton & Co; 1880;
  5. Greenwood M. A report on the natural duration of cancer: reports on public health and medical subjects, No. 33. H.M.S.O., London, 1926
  6. Bloom HJG. Survival of women with untreated breast cancer – past and present. In:  Forrest APM,  Kunkler PB editor. Prognostic Factors in Breast Cancer. Edinburgh: E&S Livingston Ltd.; 1968;
  7. MacKay EN, Sellers AH. Breast cancer at the Ontario Cancer Clinics, 1938–1956. A statistical review. Medical statistics branch, Ontario department of health, 1965
  8. Steckler RM, Martin RG. Prolonged survival in untreated breast cancer. Am J Surg. 1973;126:111–119
  9. Halsted WS. The results of operations for the cure of cancer of the breast performed at The Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Rep. 1894;4:297–350
  10.  Virchow R editors. Die Krankhaften Geschwulste. Vol. 1. Berlin: Hirshwald Publishers; 1863–1873;
  11. Lewis D, Rienhoff WFJ. A study of results of operations for the cure of cancer of the breast. Ann Surg. 1932;95:336
  12. Halsted WS. The training of the surgeon. In:  Halsted William Stewart editors. Surgical Papers. Vol. 2:Baltimore: The Johns Hopkins Press; 1924;
  13. Urban J. Management of operable breast cancer: the surgeon’s view. Cancer. 1978;42:2066
  14. Meier P, Ferguson DJ, Karrison T. A controlled trial of extended radical mastectomy. Cancer. 1985;55:880–891
  15. Lacour J, Le M, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer. 1983;51:1941–1943
  16. Brinkley D, Haybittle JL. A 15 year follow up study of patients treated for carcinoma of the breast. Br J Radiol. 1968;41:215–221
  17. Brinkley D, Haybittle JL. The curability of breast cancer. Lancet. 1975;2:9–14
  18. Fisher B. Laboratory and clinical research in breast cancer: a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res. 1980;40:3863–3874
  19. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 1992, 339, 1–15, 71–85
  20. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of randomized trials. N Engl J Med 1995, 333, 1444–1445
  21. Nystrom L, Andersson I, Bjurstam L, et al. Long term effects of mammographic screening: updated overview of the Swedish randomized trials. Lancet. 2002;359:909–919
  22. Gotsche PC, Olsen O. Is screening for breast cancer by mammography justifiable. Lancet. 2000;355:129–134
  23. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b. Trial N Engl J Med. 1997;337:949–955
  24. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  25. Skipper HE. Kinetics of mammary tumor cell growth and implications for therapy. Cancer. 1971;28:1479–1499
  26. Frei III E, Teicher B, Holden SA, et al. Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Res. 1988;48:6417–6423
  27. Frei III E, Antman K, Teicher B, et al. Bone marrow autotransplantation for solid tumours–prospects. J Clin Oncol. 1989;7:515–526
  28. Baum M, Badwe RA. Does surgery influence the natural history of breast cancer?. In:  Wise H,  Johnson HJ editor. Breast Cancer: Controversies in Management. Armonk, NY: Futura; 1994;p. 61–69
  29. Naumov GN, MacDonald IC, Weinmeister PM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res. 2002;62(April 1):2162–2168
  30. Klauber-DeMore N, et al. Biological behavior of human breast cancer micrometasteses. Clin Cancer Res. 2001;7(Aug):2434–2439
  31. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27–31
  32. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta analysis. JAMA. 1995;273:149–154
  33. Schipper H, Turley EA, Baum M. A new biological framework for cancer research. Lancet. 1996;348:1149–1151
  34. Schipper H. Historic milestones in cancer biology: a few that are important in cancer treatment. Semin Oncol. 1979;6:506–514
  35. Baum M, Vaidya JS, Mittra I. Multicentricity and recurrence of breast cancer. Lancet. 1997;349:208
  36. Whitmore WFJ. The natural history of prostate cancer. Cancer. 1973;32:1104–1112
  37. Demicheli R, Terenziani M, Valagussa P, et al. Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst. 1994;86:45–48
  38. Demicheli R, Retsky MW, Swartzendruber DE, et al. Proposal for a new model of breast cancer metastatic development. Ann Oncol. 1997;8:1075–1080
  39. Retsky M, Demicheli R, Hrushesky W. Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res Treat. 2001;65:217–224
  40. Fisher B, Gunduz N, Coile J, et al. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res. 1989;49:1996–2001
  41. Baum M, Chaplain M, Anderson A, et al. Does breast cancer exist in a state of chaos. Eur J Cancer. 1999;35:886–891
  42. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182–1186
  43. Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989;339:58–61
  44. Folkman J. What is the evidence that tumors are angiogenesis dependent [editorial]. J Natl Cancer Inst. 1990;82:4–6
  45. Retsky M, Demicheli R, Hrushesky W. Breast cancer screening: controversies and future directions. Curr Opin Obstet Gynecol. 2003;15:1–8
  46. Garvin S, Dabrosin C. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. Cancer Res. 2003;63(24):8742–8748
  47. Hrushesky WJM, Bluming AZ, Gruber SA, et al. Menstrual influence on surgical cure of breast cancer. Lancet. 1989;2:949–953
  48. Bove K, Lincoln DW, Wood PA, et al. Fertility cycle influence on surgical breast cancer cure. Breast Cancer Res Treat. 2002;75(1):65–72
  49. Baum M, Benson JR. Current and future roles of adjuvant endocrine therapy in management of early carcinoma of the breast. In:  Senn HJ,  Gelber RD,  Goldhirsch A, et al. editor. Recent Results in Cancer Research – Adjuvant Therapy of Breast Cancer. Heidelberg: Springer; 1996;p. 215–226
  50. Retsky M, Bonadonna G, Demicheli R, et al. Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients. Breast Cancer Res. 2004;6:R372–R374
  51. Baum M. Does the act of surgery provoke activation of latent metastases in early breast cancer. Breast Cancer Res. 2004;6(4):160–161Epub 2004 Jun 09
  52. Fisher ER, Sass R, Fisher B. Pathologic findings from the national adjuvant project for breast cancers (protocol no. 4). Cancer. 1984;53(3 Suppl):712–723
  53. Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 1996;14:2738–2746

PII: S0959-8049(04)00980-3

doi: 10.1016/j.ejca.2004.09.031

European Journal of Cancer
Volume 41, Issue 4 , Pages 508-515 , March 2005

Article Tools

* Image Usage & Resolution